Cannabinoid receptor 1 promotes hepatic lipid accumulation and lipotoxicity through the induction of SREBP-1c expression in zebrafish

Transgenic Research

Volumn 22, Issue 4, 2013, Pages 823-838

  Pai, Wan Yu ^a   Hsu, Chia Chun ^b   Lai, Chi Yu ^a   Chang, Trent Zarng ^a   Tsai, Yu Lun ^a   Her, Guor Mour ^a  

^a NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Cannabinoid receptor 1; Hepatic steatosis; Lipid metabolism; Transgenic zebrafish

Indexed keywords

CANNABINOID 1 RECEPTOR; CNR1 PROTEIN, RAT; LIPID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ADULT; ANIMAL; ARTICLE; GENETICS; HUMAN; LIPID METABOLISM; LIVER; LIVER CELL; METABOLISM; OBESITY; TRANSGENIC ANIMAL; ZEBRA FISH;

ADULT; ANIMALS; ANIMALS, GENETICALLY MODIFIED; HEPATOCYTES; HUMANS; LIPID METABOLISM; LIPIDS; LIVER; OBESITY; RECEPTOR, CANNABINOID, CB1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; ZEBRAFISH;

DANIO RERIO; MAMMALIA;

EID: 84880511522     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-012-9685-0     Document Type: Article

References (48)

1. Agudo J, Martin M, Roca C, Molas M, Bura AS, Zimmer A, Bosch F, Maldonado R (2010) Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age. Diabetologia 53(12): 2629-2640.
2. Anezaki Y, Ohshima S, Ishii H, Kinoshita N, Dohmen T, Kataoka E, Sato W, Iizuka M, Goto T, Sasaki J, Sasaki T, Suzuki A, Ohnishi H, Horie Y (2009) Sex difference in the liver of hepatocyte-specific Pten-deficient mice: a model of nonalcoholic steatohepatitis. Hepatol Res 39(6): 609-618.
3. Batkai S, Jarai Z, Wagner JA, Goparaju SK, Varga K, Liu J, Wang L, Mirshahi F, Khanolkar AD, Makriyannis A, Urbaschek R, Garcia N Jr, Sanyal AJ, Kunos G (2001) Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 7(7): 827-832.
4. Bellocchio L, Lafenetre P, Cannich A, Cota D, Puente N, Grandes P, Chaouloff F, Piazza PV, Marsicano G (2010) Bimodal control of stimulated food intake by the endocannabinoid system. Nat Neurosci 13(3): 281-283.
5. Bensaid M, Gary-Bobo M, Esclangon A, Maffrand JP, Le Fur G, Oury-Donat F, Soubrie P (2003) The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 63(4): 908-914.
6. Braida D, Limonta V, Pegorini S, Zani A, Guerini-Rocco C, Gori E, Sala M (2007) Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement. Psychopharmacology 190(4): 441-448.
7. Brown MS, Goldstein JL (1998) Sterol regulatory element binding proteins (SREBPs): controllers of lipid synthesis and cellular uptake. Nutr Rev 56(2 Pt 2): S1-3; discussion S54-75.
8. Chen LJ, Hsu CC, Hong JR, Jou LK, Tseng HC, Wu JL, Liou YC, Her GM (2008) Liver-specific expression of p53-negative regulator mdm2 leads to growth retardation and fragile liver in zebrafish. Dev Dyn 237(4): 1070-1081.
9. Cristino L, de Petrocellis L, Pryce G, Baker D, Guglielmotti V, Di Marzo V (2006) Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 139(4): 1405-1415.
10. Cusi K (2012) Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 142(4): 711-725 e716.
11. Despres JP, Golay A, Sjostrom L (2005) Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 353(20): 2121-2134.
12. Deveaux V, Cadoudal T, Ichigotani Y, Teixeira-Clerc F, Louvet A, Manin S, Nhieu JT, Belot MP, Zimmer A, Even P, Cani PD, Knauf C, Burcelin R, Bertola A, Le Marchand-Brustel Y, Gual P, Mallat A, Lotersztajn S (2009) Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. PLoS ONE 4(6): e5844.
13. Di Marzo V, Matias I (2005) Endocannabinoid control of food intake and energy balance. Nat Neurosci 8(5): 585-589.
14. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kunos G (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410(6830): 822-825.
15. Gary-Bobo M, Elachouri G, Gallas JF, Janiak P, Marini P, Ravinet-Trillou C, Chabbert M, Cruccioli N, Pfersdorff C, Roque C, Arnone M, Croci T, Soubrie P, Oury-Donat F, Maffrand JP, Scatton B, Lacheretz F, Le Fur G, Herbert JM, Bensaid M (2007) Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. Hepatology 46(1): 122-129.
16. Harvey-Girard E, Giassi AC, Ellis W, Maler L (2012) Expression of the cannabinoid CB1 receptor in the gymnotiform fish brain and its implications for the organization of the teleost pallium. J Comp Neurol. doi: 10. 1002/cne. 23212.
17. Her GM, Chiang CC, Chen WY, Wu JL (2003) In vivo studies of liver-type fatty acid binding protein (L-FABP) gene expression in liver of transgenic zebrafish (Danio rerio). FEBS Lett 538(1-3): 125-133.
18. Her GM, Cheng CH, Hong JR, Sundaram GS, Wu JL (2006) Imbalance in liver homeostasis leading to hyperplasia by overexpressing either one of the Bcl-2-related genes, zfBLP1 and zfMcl-1a. Dev Dyn 235(2): 515-523.
19. Her GM, Hsu CC, Hong JR, Lai CY, Hsu MC, Pang HW, Chan SK, Pai WY (2011) Overexpression of gankyrin induces liver steatosis in zebrafish (Danio rerio). Biochim Biophys Acta 1811(9): 536-548.
20. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11(2): 563-583.
21. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54(2): 161-202.
22. Julien B, Grenard P, Teixeira-Clerc F, van Nhieu JT, Li L, Karsak M, Zimmer A, Mallat A, Lotersztajn S (2005) Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 128(3): 742-755.
23. Lam CS, Rastegar S, Strahle U (2006) Distribution of cannabinoid receptor 1 in the CNS of zebrafish. Neuroscience 138(1): 83-95.
24. Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L (2009) Molecular mechanisms involved in NAFLD progression. J Mol Med (Berl) 87(7): 679-695.
25. Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C (2008) Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med 14(2): 72-81.
26. McPartland JM, Glass M, Matias I, Norris RW, Kilpatrick CW (2007) A shifted repertoire of endocannabinoid genes in the zebrafish (Danio rerio). Mol Genet Genomics 277(5): 555-570.
27. Mendez-Sanchez N, Zamora-Valdes D, Pichardo-Bahena R, Barredo-Prieto B, Ponciano-Rodriguez G, Bermejo-Martinez L, Chavez-Tapia NC, Baptista-Gonzalez HA, Uribe M (2007) Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease. Liver Int 27(2): 215-219.
28. Migliarini B, Carnevali O (2008) Anandamide modulates growth and lipid metabolism in the zebrafish Danio rerio. Mol Cell Endocrinol 286 (1-2 Suppl 1): S12-S16.
29. Migliarini B, Carnevali O (2009) A novel role for the endocannabinoid system during zebrafish development. Mol Cell Endocrinol 299(2): 172-177.
30. Migliarini B, Marucci G, Ghelfi F, Carnevali O (2006) Endocannabinoid system in Xenopus laevis development: CB1 receptor dynamics. FEBS Lett 580(8): 1941-1945.
31. Nishio S, Gibert Y, Berekelya L, Bernard L, Brunet F, Guillot E, Le Bail JC, Sanchez JA, Galzin AM, Triqueneaux G, Laudet V (2012) Fasting induces CART down-regulation in the Zebrafish nervous system in a cannabinoid receptor 1-dependent manner. Mol Endocrinol 26(8): 1316-1326.
32. Nogueiras R, Veyrat-Durebex C, Suchanek PM, Klein M, Tschop J, Caldwell C, Woods SC, Wittmann G, Watanabe M, Liposits Z, Fekete C, Reizes O, Rohner-Jeanrenaud F, Tschop MH (2008) Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats. Diabetes 57(11): 2977-2991.
33. Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, Batkai S, Harvey-White J, Mackie K, Offertaler L, Wang L, Kunos G (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115(5): 1298-1305.
34. Osei-Hyiaman D, Liu J, Zhou L, Godlewski G, Harvey-White J, Jeong WI, Batkai S, Marsicano G, Lutz B, Buettner C, Kunos G (2008) Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest 118(9): 3160-3169.
35. Pacher P, Batkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58(3): 389-462.
36. Porter AC, Felder CC (2001) The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol Ther 90(1): 45-60.
37. Provost E, Rhee J, Leach SD (2007) Viral 2A peptides allow expression of multiple proteins from a single ORF in transgenic zebrafish embryos. Genesis 45(10): 625-629.
38. Salamone F, Galvano F, Cappello F, Mangiameli A, Barbagallo I, Li Volti G (2012) Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. Transl Res 159(6): 477-486.
39. Shieh YS, Chang YS, Hong JR, Chen LJ, Jou LK, Hsu CC, Her GM (2010) Increase of hepatic fat accumulation by liver specific expression of Hepatitis B virus × protein in zebrafish. Biochim Biophys Acta 1801(7): 721-730.
40. Stincic TL, Hyson RL (2011) The localization and physiological effects of cannabinoid receptor 1 in the brain stem auditory system of the chick. Neuroscience 194: 150-159.
41. Tam J, Vemuri VK, Liu J, Batkai S, Mukhopadhyay B, Godlewski G, Osei-Hyiaman D, Ohnuma S, Ambudkar SV, Pickel J, Makriyannis A, Kunos G (2010) Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. J Clin Invest 120(8): 2953-2966.
42. Tedesco L, Valerio A, Cervino C, Cardile A, Pagano C, Vettor R, Pasquali R, Carruba MO, Marsicano G, Lutz B, Pagotto U, Nisoli E (2008) Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes. Diabetes 57(8): 2028-2036.
43. Teixeira-Clerc F, Belot MP, Manin S, Deveaux V, Cadoudal T, Chobert MN, Louvet A, Zimmer A, Tordjmann T, Mallat A, Lotersztajn S (2010) Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration. Hepatology 52(3): 1046-1059.
44. Tilg H, Moschen AR (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52(5): 1836-1846.
45. Valenti M, Cottone E, Martinez R, De Pedro N, Rubio M, Viveros MP, Franzoni MF, Delgado MJ, Di Marzo V (2005) The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake. J Neurochem 95(3): 662-672.
46. Westerbacka J, Kotronen A, Fielding BA, Wahren J, Hodson L, Perttila J, Seppanen-Laakso T, Suortti T, Arola J, Hultcrantz R, Castillo S, Olkkonen VM, Frayn KN, Oresic M, Yki-Jarvinen H (2010) Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease. Gastroenterology 139(6): 1961-1971 e1961.
47. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112(1): 91-100.
48. Xu X, Liu Y, Huang S, Liu G, Xie C, Zhou J, Fan W, Li Q, Wang Q, Zhong D, Miao X (2006) Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma. Cancer Genet Cytogenet 171(1): 31-38.